USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
19 Oct 2022 | 09:00 AM GMT

Success Metrics of Patient Engagement with DTx Solutions

Anchored by:

Aahuti Rai
NED, Advisor & Venture Partner
FOUR POINTS HEALTH | CONDUIT CONNECT

Participants:

Aahuti Rai NED, Advisor & Venture PartnerFour Points Health | Conduit Connect
Aahuti Rai
NED, Advisor & Venture PartnerFour Points Health | Conduit Connect
Andy Freeburn Head of Product and DesignVine Health
Andy Freeburn
Head of Product and DesignVine Health
Elaina Bolinger Senior Insights ManagerBayer AG
Elaina Bolinger
Senior Insights ManagerBayer AG
Emma Carr Co-Founder and Chief Scientific OfficerAmara Therapeutics
Emma Carr
Co-Founder and Chief Scientific OfficerAmara Therapeutics
JD
Johanna Denham-Harding Co Founderaltern
JD
Johanna Denham-Harding
Co Founderaltern
Malin Johansson Vice PresidentNovo Nordisk
Malin Johansson
Vice PresidentNovo Nordisk
Matt Norton VP of Marketing & Commercial DevelopmentS3 Connected Health
Matt Norton
VP of Marketing & Commercial DevelopmentS3 Connected Health
Susanne Gruber Strategic Healthcare AdvisorIgnited Vision
Susanne Gruber
Strategic Healthcare AdvisorIgnited Vision
Thyago Ohana Digital Strategy & Capabilities LeadUCB Pharma
Thyago Ohana
Digital Strategy & Capabilities LeadUCB Pharma
Zina Manji Founder/Principal, Regulatory StrategistInnopathwayz, LLC
Zina Manji
Founder/Principal, Regulatory StrategistInnopathwayz, LLC

About this Meeting

In a world where customers are used to excellent user experience (e.g. Google, Amazon, Apple, etc.), DTx companies need to meet customers’ expectations. As opposed to other industries, DTx companies have multiple stakeholders to please and innovators must find a way to prioritize patients before considering the other stakeholders when it comes to driving patient adoption. But what does successful patient engagement with DTx look like?  

Join this session to discuss with other senior leaders what the success metrics of patient engagement are for DTx solutions:  

  • What does the term "patient engagement" really mean for digital therapies? What does an engaged patient look like?  
  • The healthcare industry is used to working with standards to understand what is good and what is not. Standardizing good patient engagement with DTx is harder, but are there any standards that can help the industry distinguish what is good and what is not? 
  • Patient engagement metrics can be initially gathered in pilots or studies, but performance in the real market is different. What are the best real-world data points to demonstrate successful patient utilization?  
  • What are good success metrics on patient activation and optimate onboarding? 
  • Long-term patient retention: what metrics can be used to measure long-term patient engagement with DTx? What are good success metrics for DTx interventions that aim to change patient behavior for good after 2 or 3 months of therapy? 
  • What are good examples in the industry and what can we learn from them?